Back to Search
SHERYL MORRIS, RPH
RPH
Pharmacist
NPI: 1083783658Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
12353(AL)
Clinical Trials (4)
4
Linked Trials
0
Recruiting
3
With Results
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
NCT04616963ACTIVE_NOT_RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery
NCT00925756COMPLETEDPHASE4STUDY_CHAIR
Effect of Vitamin D Supplementation on Bone Turnover Markers During PrEP in MSM
NCT02367599COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women
NCT02584140COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (3)
Comparison of Existing and New Race- and Sex-Free Kidney Function Equations in Transgender Adults without CKD.
PMID 40694414·Clin J Am Soc Nephrol·2025
8-other
The impact of intimate partner violence on PrEP adherence among U.S. Cisgender women at risk for HIV.
PMID 38822300·BMC Public Health·2024
3-trial
Pre-Exposure Prophylaxis Perspectives, Sociodemographic Characteristics, and HIV Risk Profiles of Cisgender Women Seeking and Initiating PrEP in a US Demonstration Project.
PMID 34851726·AIDS Patient Care STDS·2021
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6300 GRELOT RD
MOBILE, AL 36609 - Phone
- (251) 633-4938
Quick Facts
- NPI
- 1083783658
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 3
Are you this provider?
Claim Your Profile